Ddavp (needs No Refrigeration) is a drug owned by Ferring Pharmaceuticals Inc. It is protected by 4 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Dec 23, 2013. Details of Ddavp (needs No Refrigeration)'s patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5674850 | High purity desmopressin produced in large single batches |
Dec, 2013
(10 years ago) |
Expired
|
| US5482931 | Stabilized pharmaceutical peptide compositions |
Jun, 2013
(11 years ago) |
Expired
|
| US5500413 | Process for manufacture of 1-deamino-8-D-arginine vasopressin |
Jun, 2013
(11 years ago) |
Expired
|
| US5763407 | High-purity desmopressin produced in large single batches |
Jun, 2013
(11 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Ddavp (needs No Refrigeration) is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Ddavp (needs No Refrigeration)'s family patents as well as insights into ongoing legal events on those patents.
Ddavp (needs No Refrigeration)'s Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Ddavp (needs No Refrigeration)'s generic launch date based on the expiry of its last outstanding patent is estimated to be Dec 23, 2013 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Ddavp (needs No Refrigeration) Generic API suppliers:
Desmopressin Acetate is the generic name for the brand Ddavp (needs No Refrigeration). 24 different companies have already filed for the generic of Ddavp (needs No Refrigeration), with Abhai Llc having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Ddavp (needs No Refrigeration)'s generic
How can I launch a generic of Ddavp (needs No Refrigeration) before its drug patent expiration? :
You can seek FDA approval to launch a generic drug before the expiration of Ddavp (needs No Refrigeration)'s patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the Ddavp (needs No Refrigeration)'s sponsor is invalid, unenforceable, or will not be infringed by your generic product.
Given below are the details of the already filed Para IV certificates on Ddavp (needs No Refrigeration) -
| Strength | Submission Date | ANDA(s) Filed | First applicant approval | Last patent expiry | 180 day status |
|---|---|---|---|---|---|
| 0.0001 |
Alternative Brands for Ddavp (needs No Refrigeration)
Ddavp (needs No Refrigeration) which is used for treating moderate to severe pain., has several other brand drugs using the same active ingredient (Desmopressin Acetate). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | ||
|---|---|---|---|
| Acerus Pharms |
| ||
| Ferring |
| ||
| Ferring Pharms Inc |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Desmopressin Acetate, Ddavp (needs No Refrigeration)'s active ingredient. Check the complete list of approved generic manufacturers for Ddavp (needs No Refrigeration)
About Ddavp (needs No Refrigeration)
Ddavp (Needs No Refrigeration) is a drug owned by Ferring Pharmaceuticals Inc. It is used for treating moderate to severe pain. Ddavp (Needs No Refrigeration) uses Desmopressin Acetate as an active ingredient. Ddavp (Needs No Refrigeration) was launched by Ferring Pharms Inc in 1982.
Approval Date:
Ddavp (needs No Refrigeration) was approved by FDA for market use on 01 January, 1982.
Active Ingredient:
Ddavp (needs No Refrigeration) uses Desmopressin Acetate as the active ingredient. Check out other Drugs and Companies using Desmopressin Acetate ingredient
Treatment:
Ddavp (needs No Refrigeration) is used for treating moderate to severe pain.
Dosage:
Ddavp (needs No Refrigeration) is available in spray, metered form for nasal use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 0.01MG/SPRAY | SPRAY, METERED | Discontinued | NASAL |